Skip to content
Screener

eXoZymes, Inc. EXOZ EPS (Diluted)

EPS (Diluted) at other companies

Gevo logo
GevoGEVO
-$0.75-7,600%
NAG
Niagen BioscienceNAGE
$0.07+16.7%
Opko Health logo
Opko HealthOPK
-$0.01+94.7%
LifeVantage Corporation logo
LifeVantage CorporationLFVN
$0.10-33.3%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$2.15+18.1%
Nature's Sunshine Products logo
Nature's Sunshine ProductsNATR
$0.19-32.1%

Other financials

Income statement

See full
Revenue$17.5K
Operating income-$2.4M-22.4%
Net income-$2.4M-27.7%

Balance sheet

See full
Cash & equivalents$1.4M-83.0%
Total debt$1.2M-8.8%
Total equity$1.5M-82.8%
Total assets$4.0M-65.1%

Cash flow

See full
Operating cash flow-$1.5M-34.5%
CapEx$57.6K+85.5%
Free cash flow-$1.6M-35.8%

Valuation

See full
Market cap$69.84M-14.2%
Enterprise value$69.61M-8.2%

Profitability

See full
Net margin-2,909.1%

Returns & leverage

See full
Return on equity-185.8%
Debt / equity0.8×+0.6×
Current ratio1.3×-5.2×

Where this comes from

Reported directly by eXoZymes, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.

The source filing: eXoZymes, Inc.’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 3:50 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001493152-26-023035

FAQ

What is eXoZymes, Inc.'s EPS (diluted)?
eXoZymes, Inc. (EXOZ) reported EPS (diluted) of -$0.28 in Q1 2026.
How has eXoZymes, Inc.'s EPS (diluted) changed year-over-year?
eXoZymes, Inc.'s EPS (diluted) decreased by 27.3% year-over-year, from -$0.22 to -$0.28.
What does EPS (diluted) mean?
Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.

Ask your AI about eXoZymes, Inc.'s eps (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude